Скачать или смотреть AzurRx BioPharma (NASDAQ: AZRX) | James Sapirstein, President & CEO | Innovators with Jane King

Jane King interviews James Sapirstein, the President & CEO of AzurRx BioPharma (NASDAQ: AZRX). https://www.azurrx.com/

Segment from TV Show 'Innovators with Jane King'.

'Innovators with Jane King' profiles tech companies and thought leaders in the space. We're showing you a glimpse of the future.

AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) focused on the development of recombinant proteins for the treatment of gastrointestinal diseases. Our therapeutic products will be administered to patients as oral non-systemic biologics. The company's lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency (for cystic fibrosis and chronic pancreatitis patients). The company is headquartered in New York City, with scientific operations in Langlade, France and clinical operations in Hayward, California.

https://www.azurrx.com/